Table 3.
Distribution of the SW/3/06 virus in experimentally inoculated mice
Inoculation route | Dose (EID 50 ) | Hpi | Viral titer (log 10 EID 50 /0.1 mL, mean ± standard deviation) | MLD 50 (EID 50 ) | MID 50 (EID 50 ) | ||||
---|---|---|---|---|---|---|---|---|---|
Lung | Brain | Liver | Spleen | Kidney | |||||
I.n. | 104.0 | 30-48 | 6.4 ± 0.7 | 1.9 ± 0.1 | 2.7 ± 0.6 | 4.2 ± 1.0 | 4.1 ± 0.8 | 2.9 | 1.7 |
I.m. | 104.0 | 48-72 | 6.2 ± 0.8 | 1.8 ± 0.1 | 2.0 ± 0.4 | 3.6 ± 0.5 | 3.5 ± 1.5 |
BALB/c mice (five per group) were inoculated intranasally or intramuscularly with 104.0 EID50/50 μl of SW/3/06 virus. To assess mouse LD50 (MLD50), the mice were inoculated with 10-fold serial dilutions of 106.0 EID50 of SW/3/06 virus (100.0 to 107.0) via the intranasal route and observed for 14 days. To assess mouse ID50 (MID50), lung tissues were collected from three inoculated mice per group at 3 dpi. The lower virus detection limit was 101.75 EID50/g.
Hpi, hour post infection.